B and T cell epitope mapping and study the humoral and cell mediated immune response to B-T constructs of YscF antigen of Yersinia pestis

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 36, Issue 4, 2013, Pages 365-378

  Ali, Riyasat ^a   Kumar, Sudhir ^a   Naqvi, Raza Ali ^a   Rao, D N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

B T construct; Cytokine; Epitope; Yersinia pestis; YscF antigen

Indexed keywords

ASPARAGINYLPHENYLALANYLSERYLGLYCYLPHENYLALANYLTHREONYLLYSYLGLYCYLTHREONYLASPARTYLISOLEUCYLALANYLASPARTYLLEUCYLASPARTYLALANYLVALYLALANINE; ASPARTYLSERYLISOLEUCYLALANYLALANYLLEUCYLLYSYLASPARTYLLYSYLPROLYLASPARTYLASPARAGINYLPROLYLALANYLLEUCINE; BACTERIAL ANTIGEN; BACTERIAL VACCINE; CYTOKINE; EPITOPE; GAMMA INTERFERON; GLUTAMINYLTHREONYLLEUCYLLYSYLLYSYLPROLYLALANYLASPARTYLASPARTYLALANYLASPARAGINYLLYSYLALANYLVALYLASPARAGINYLASPARTYLSERINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 2; INTERLEUKIN 4; LEUCYLEUCYLALANYLASPARTYLLEUCYLGLUTAMINYLHISTIDINYLSERYLISOLEUCYLASPARAGINYLLYSYLTRPTOPHYLSERYLVALYLISOLEUCYLTYROSINE; PEPTIDE DERIVATIVE; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG; VALYLISOLEUCYLTYROSYLASPARAGINYLISOLEUCYLASPARAGINYLSERYLTHREONYLISOLEUCYLVALYLARGINYLSERYLMETHIONYLLYSYLASPARTYLLEUCYLMETHIONYLGLUTAMINE; YERSINIA PESTIS VACCINE; YSCF ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; COMPUTER PROGRAM; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMORAL IMMUNITY; IMMUNOASSAY; IMMUNOGENICITY; INTESTINE; LAMINA PROPRIA; LUNG; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PEYER PATCH; PREDICTION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SPLEEN; T LYMPHOCYTE; YERSINIA PESTIS;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; BLOTTING, WESTERN; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; IMMUNIZATION; LYMPHOID TISSUE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PLAGUE; STATISTICS, NONPARAMETRIC; YERSINIA PESTIS;

MURINAE; MUS; YERSINIA PESTIS;

EID: 84879001790     PISSN: 01479571     EISSN: 18781667     Source Type: Journal    
DOI: 10.1016/j.cimid.2013.01.002     Document Type: Article

References (36)

1. Inglesby T.V., Dennis D.T., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. Journal of the American Medical Association 2000, 17:2281-2290.
2. Meyer K.F. Effectiveness of live or killed plague vaccines in man. Bulletin of the World Health Organization 1970, 5:653-666.
3. Titball R.W., Williamson E.D. Yersinia pestis (plague) vaccines. Expert Opinion on Biological Therapy 2004, 6:965-973.
4. Williamson E.D. Recombinant (F1+V) vaccine protects Cynomolgus macaques against pneumonic plague. Vaccine 2011, 24:4771-4777.
5. Titball R.W., Williamson E.D. Vaccination against bubonic and pneumonic plague. Vaccine 2001, 30:4175-4184.
6. Anderson G.W.J., Heath D.G., Bolt C.R., Welkos S.L., Friedlander A.M. Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice. American Journal of Tropical Medicine and Hygiene 1998, 6:793-799.
7. Du Y., Galyov E., Forsberg A. Genetic analysis of virulence determinants unique to Yersinia pestis. Contributions to Microbiology and Immunology 1995, 13:321-324.
8. Davis K.J., Fritz D.L., Pitt M.L., Welkos S.L., Worsham P.L., Friedlander A.M. Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops). Archives of Pathology and Laboratory Medicine 1996, 2:156-163.
9. Drozdov I.G., Anisimov A.P., Samoilova S.V., Yezhov I.N., Yeremin S.A., Karlyshev A.V., et al. Virulent non-capsulate Yersinia pestis variants constructed by insertion mutagenesis. Journal of Medical Microbiology 1995, 4:264-268.
10. Nedialkov Y.A., Motin V.L., Brubaker R.R. Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10. Infection and Immunity 1997, 65:1196-1203.
11. Nakajima R., Motin V.L., Brubaker R.R. Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infection and Immunity 1995, 63:3021-3029.
12. Cornelis G.R. The Yersinia Ysc-Yop 'type III' weaponry. Nature Reviews: Molecular Cell Biology 2002, 10:742-752.
13. Kubori T., Matsushima Y. Supramolecular structure of the Salmonella typhimurium type III protein secretion system. Science 1998, 280:602-605.
14. Hoiczyk E., Bloebel G. Polymerization of a single protein of the pathogen Yersinia enterocolitica into needles punctures eukaryotic cells. Proceedings of the National Academy of Sciences of the United States of America 2001, 8:4669-4674.
15. Matson J.S., Durick K.A., Bradley D.S., Nilles M.L. Immunization of mice with YscF provides protection from Yersinia pestis infections. BMC Microbiology 2005, 5:38.
16. Swietnicki W., Powell B.S., Goodin J. Yersinia pestis YOP secretion protein F: purification, characterization, and protective efficacy against bubonic plague. Protein Expression and Purification 2005, 42:166-172.
17. Wang S., Joshi S., Mboudjeka I., Liu F., Ling T., Goguen J.D., et al. Relative immunogenicity and protection potential of candidate Yersinia pestis antigens against lethal mucosal plague challenge in Balb/C mice. Vaccine 2008, 13:1664-1674.
18. Wang S., Mboudjeka I., Goguen J.D., Lu S. Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines. Vaccine 2010, 28:2011-2019.
19. Khan A.A., Babu J.P., Gupta G., Rao D.N. Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis. Vaccine 2008, 3:316-332.
20. Sabhnani L., Rao D.N. Identification of immunodominant epitope of F1 antigen of Yersinia pestis. FEMS Immunology and Medical Microbiology 2000, 2:155-162.
21. Tripathi V., Chitralekha K.T., Bakshi A.R., Tomar D., Deshmukh R.A., Baig M. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery. Vaccine 2006, 16:3279-3289.
22. + T-cell expression and IFN-γ, perforin secretion for B-T constructs of F1 and V antigens of Yersinia pestis. International Immunopharmacology 2012, 12:64-73.
23. Uppada J.B., Rao D.N. Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of V antigen of Yersinia pestis in microparticle delivery by intranasal immunization. Medical Microbiology and Immunology 2009, 4:247-256.
24. Gupta G., Khan A.A., Rao D.N. Cell-mediated immune response and Th1/Th2 cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis. Scandinavian Journal of Immunology 2010, 71:186-198.
25. Chong P., Sia C., Tam E., Kandil A., Klein M. Synthesis and immunological characterization of a 134-mer synthetic peptide corresponding to the N-terminal half of the HIV-1 nucleoprotein. International Journal of Peptide and Protein Research 1993, 41:21-27.
26. Smith D.D., Conlon J.M., Petzel J., Chen L., Murphy R.F., Morley B.J. Solid-phase peptide synthesis and biological activity of bovine thymopoietin II (bTP-II). International Journal of Peptide and Protein Research 1994, 44:183-191.
27. Roggrero M.A., Servis C., Corradin G. A simple and rapid procedure for the purification of synthetic polypeptides by a combination of affinity chromatography and methionine chemistry. FEBS Letters 1997, 408:285-288.
28. Bhasin M., Raghava G.P.S. Prediction of CTL epitopes using QM, SVM and ANN techniques. Vaccine 2004, 22:3195-3201.
29. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100:655-669.
30. Zheng W., Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4T cells. Cell 1997, 89:587-596.
31. Croft M., Swain S.L. B cell response to T helper cell subsets. II. Both the stage of T cell differentiation and the cytokines secreted determine the extent and nature of helper activity. Journal of Immunology 1991, 147:3679-3689.
32. Kerzchen E.J., Cohen D.A., Kalpan A.M., Straley S.C. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infection and Immunity 2004, 72(8):4589-4602.
33. Li B., Yang R. Interaction between Yersinia pestis and the host immune system. Infection and Immunity 2008, 76:1804-1811.
34. Elvin S.J., Williamson E.D. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague. Microbial Pathogenesis 2004, 37:177-184.
35. Mitaku S., Hirokawa T., Tsuji T. Amphiphilicity index of polar amino acids as an aid in the characterization of amino acid preference at membrane-water interfaces. Bioinformatics 2002, 18:608-616.
36. Rost B., Sander C. PHDacc predicts per residue solvent accessibility from multiple sequence alignments. Proteins 1994, 20:216-226.